Ozempic, Wegovy linked to uncommon circumstances of eye dysfunction, EMA says – Nationwide
Descrease article font size Increase article font size The European Medicines Agency’s safety committee has concluded that the use of Novo Nordisk’s popular weight-loss drug Wegovy and its treatments for type 2 diabetes may cause rare occurrences of a potentially dangerous eye condition. Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up … Read more